605 Study of safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis
Journal of Investigative Dermatology（2018）
Key words
dermatomyositis,cannabinoid receptor type,lenabasum,skin-predominant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined